Streetbeat News

Equity Actions

CLLS

Cellectis (NASDAQ:CLLS), a clinical-stage biotechnology company, announced the resignation of CFO Bing Wang and the appointment of Arthur Stril as interim CFO. Stril, who joined Cellectis in 2018 and served as Chief Business Officer since 2020, will oversee finance, investor relations, and continue his business development role. The company praised Wang's contributions and expressed confidence in Stril's capabilities to support Cellectis' growth and clinical trials advancement.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:35 pm

CDXS

Codexis, identified by its ticker CDXS, has filed for a $200M mixed securities shelf, allowing the company to issue various types of securities in the future.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:29 pm

CTAS

Cintas Corporation (NASDAQ:CTAS) announced a 4-for-1 stock split, effective September 12, 2024, aimed at increasing stock accessibility for investors and employee-partners. Shareholders on record as of September 4, 2024, will receive three additional shares for each share held, with the distribution occurring after market close on September 11, 2024. This move is expected to increase the outstanding common stock from about 101 million shares to approximately 404 million shares. The decision reflects Cintas' strong performance and desire to make share ownership more attainable.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:28 pm

OPEN

Opendoor Technologies has filed for a mixed securities shelf, allowing the company to issue various types of securities in the future.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:23 pm

TOVX

Theriva Biologics has filed for a mixed-securities shelf, allowing the company to issue various types of securities in the future. This move could provide Theriva with the flexibility to raise capital as needed for operations, research, and development.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:21 pm

PCTY

Paylocity Holding's shares surged following the announcement of Q3 financial results that exceeded expectations. The company also provided optimistic Q4 and FY24 revenue guidance, alongside a $500 million share repurchase program approved by the Board of Directors.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:06 pm

RTX

RTX's Board has announced a 6.8% increase in its dividend to $0.63, reaffirming its commitment to return $36-$37 billion to shareholders through dividends and repurchases by 2025.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:04 pm

WTRG

Essential Utilities anticipates exceeding its 2024 net income guidance of $1.96-$2.00 per diluted share due to Q1 gains from the sale of energy plant assets, despite lower natural gas revenues from warm weather. The company plans $1.3-$1.4 billion in regulated infrastructure investments in 2024, with a total of $7.2 billion through 2028, focusing on water and natural gas segments. The water segment's rate base is expected to grow at an 8% CAGR, and the natural gas segment at a 10% CAGR through 2028. Customer bases in both segments are expected to grow, with $250 million in equity to be raised in 2024.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:04 pm

OKE

Analysts have provided diverse ratings for ONEOK (NYSE:OKE) with a range from bullish to bearish over the last three months. The average 12-month price target for OKE has increased by 6.82% to $82.36. Recent analyst actions include upgrades and raised price targets by firms such as Wells Fargo, Stifel, and Morgan Stanley, reflecting a positive outlook on the company. Despite this, ONEOK faces challenges in revenue growth, net margin, ROE, and ROA, indicating potential hurdles in financial performance.

Portfolio Pulse from Benzinga Insights

May 02, 2024 | 9:01 pm

CLFD

Clearfield reported better-than-expected Q2 results and increased its repurchase authorization, leading to a rise in its share price.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 8:49 pm